Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Interleukin-17 | 4 | 2013 | 82 | 0.870 |
Why?
|
| Interleukin-17 | 5 | 2013 | 913 | 0.630 |
Why?
|
| Melanosis | 1 | 2014 | 93 | 0.430 |
Why?
|
| Waldenstrom Macroglobulinemia | 8 | 2009 | 1074 | 0.420 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1361 | 0.410 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 925 | 0.400 |
Why?
|
| Mouth | 1 | 2014 | 381 | 0.390 |
Why?
|
| Skin Diseases | 1 | 2019 | 1095 | 0.360 |
Why?
|
| Skin | 2 | 2019 | 4473 | 0.270 |
Why?
|
| Signal Transduction | 5 | 2013 | 23415 | 0.250 |
Why?
|
| Inflammation | 3 | 2020 | 10758 | 0.230 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 10203 | 0.230 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2813 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1891 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2870 | 0.210 |
Why?
|
| Candidiasis, Oral | 2 | 2010 | 57 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2010 | 4137 | 0.170 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 5809 | 0.160 |
Why?
|
| ras Proteins | 3 | 2013 | 1054 | 0.160 |
Why?
|
| Autoimmunity | 2 | 2020 | 1354 | 0.150 |
Why?
|
| Skin Diseases, Viral | 1 | 2016 | 26 | 0.140 |
Why?
|
| Chickenpox Vaccine | 1 | 2016 | 40 | 0.140 |
Why?
|
| Melanoma | 1 | 2015 | 5694 | 0.140 |
Why?
|
| Hand Dermatoses | 1 | 2016 | 62 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9566 | 0.130 |
Why?
|
| Herpesvirus 3, Human | 1 | 2016 | 159 | 0.130 |
Why?
|
| Leg Ulcer | 1 | 2015 | 71 | 0.120 |
Why?
|
| Plasma Cells | 2 | 2009 | 597 | 0.120 |
Why?
|
| Cyclosporine | 1 | 2017 | 776 | 0.120 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2017 | 246 | 0.120 |
Why?
|
| Protein Binding | 3 | 2013 | 9300 | 0.110 |
Why?
|
| Herpes Zoster | 1 | 2016 | 253 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 252 | 0.110 |
Why?
|
| Complement Factor D | 1 | 2013 | 67 | 0.110 |
Why?
|
| Dermatomyositis | 1 | 2016 | 258 | 0.110 |
Why?
|
| Cell Line | 4 | 2013 | 15542 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4372 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 636 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2015 | 348 | 0.100 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 460 | 0.100 |
Why?
|
| Exanthema | 1 | 2016 | 503 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2015 | 559 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 551 | 0.090 |
Why?
|
| Genetic Linkage | 2 | 2007 | 2340 | 0.090 |
Why?
|
| Teaching Rounds | 1 | 2014 | 276 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2013 | 941 | 0.080 |
Why?
|
| Mast Cells | 2 | 2008 | 1392 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 614 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 1111 | 0.080 |
Why?
|
| Oropharynx | 1 | 2010 | 137 | 0.080 |
Why?
|
| Tunicamycin | 1 | 2008 | 108 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 2009 | 373 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2010 | 18926 | 0.070 |
Why?
|
| Animals | 12 | 2020 | 168083 | 0.070 |
Why?
|
| Farnesyltranstransferase | 1 | 2007 | 71 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 4 | 2008 | 9185 | 0.070 |
Why?
|
| Diacylglycerol Kinase | 1 | 2006 | 47 | 0.070 |
Why?
|
| Hepatitis C Antibodies | 1 | 2007 | 147 | 0.070 |
Why?
|
| Clonal Anergy | 1 | 2006 | 169 | 0.070 |
Why?
|
| Antigens, CD20 | 1 | 2007 | 199 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2007 | 4008 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2008 | 2621 | 0.060 |
Why?
|
| Cytokines | 1 | 2020 | 7386 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 2054 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1696 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2010 | 5033 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2010 | 5870 | 0.060 |
Why?
|
| Antibodies, Neoplasm | 1 | 2006 | 282 | 0.060 |
Why?
|
| Th1 Cells | 2 | 2007 | 1042 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2007 | 394 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4189 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 976 | 0.060 |
Why?
|
| Mastocytosis | 1 | 2006 | 150 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 752 | 0.060 |
Why?
|
| Mice | 8 | 2013 | 81324 | 0.050 |
Why?
|
| Receptors, IgG | 1 | 2007 | 558 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2007 | 1154 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12975 | 0.050 |
Why?
|
| Penetrance | 1 | 2004 | 382 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 1126 | 0.050 |
Why?
|
| Biopsy | 1 | 2014 | 6781 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 320 | 0.050 |
Why?
|
| Transfection | 1 | 2010 | 5750 | 0.050 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 341 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 564 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 1790 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2008 | 1892 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 1803 | 0.050 |
Why?
|
| Humans | 23 | 2020 | 761098 | 0.050 |
Why?
|
| Binding Sites | 1 | 2010 | 5993 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 1348 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4565 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12096 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2010 | 14393 | 0.040 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2004 | 386 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2007 | 1891 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 2197 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4933 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4021 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2007 | 1330 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 18217 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 3591 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2007 | 1372 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 2381 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1240 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2009 | 4744 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13404 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2410 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2006 | 2203 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2007 | 2839 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 1984 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1589 | 0.040 |
Why?
|
| Models, Biological | 1 | 2013 | 9455 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2007 | 1579 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 3700 | 0.030 |
Why?
|
| Buttocks | 1 | 2016 | 112 | 0.030 |
Why?
|
| Apoptosis | 2 | 2008 | 9478 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13630 | 0.030 |
Why?
|
| Virus Activation | 1 | 2016 | 319 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 2549 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9720 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2009 | 22157 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2016 | 426 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1624 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2010 | 44 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 1 | 2010 | 93 | 0.020 |
Why?
|
| Leg | 1 | 2015 | 1087 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2010 | 61 | 0.020 |
Why?
|
| Methotrexate | 1 | 2016 | 1717 | 0.020 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 9518 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2009 | 63 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17889 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11505 | 0.020 |
Why?
|
| Female | 8 | 2017 | 392458 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2007 | 70 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2007 | 103 | 0.020 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2007 | 83 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 146 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2007 | 112 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6305 | 0.020 |
Why?
|
| Gene Expression | 2 | 2009 | 7567 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1004 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 30006 | 0.020 |
Why?
|
| Adult | 4 | 2014 | 221083 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 1644 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 36164 | 0.020 |
Why?
|
| Methionine | 1 | 2007 | 570 | 0.010 |
Why?
|
| Protein Folding | 1 | 2008 | 869 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 613 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9324 | 0.010 |
Why?
|
| Phosphorylation | 2 | 2007 | 8303 | 0.010 |
Why?
|
| Interleukins | 1 | 2009 | 782 | 0.010 |
Why?
|
| Quinolones | 1 | 2007 | 378 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 694 | 0.010 |
Why?
|
| Length of Stay | 1 | 2017 | 6420 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2003 | 317 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3779 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2017 | 64670 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 207 | 0.010 |
Why?
|
| Male | 8 | 2017 | 360675 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2855 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11066 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2006 | 1682 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2475 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2007 | 1071 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2006 | 1867 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 58946 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2008 | 1406 | 0.010 |
Why?
|
| Middle Aged | 6 | 2016 | 220835 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9317 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13506 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2892 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3155 | 0.010 |
Why?
|
| Piperidines | 1 | 2007 | 1656 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3577 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 4739 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 3841 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 5478 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4243 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 39953 | 0.010 |
Why?
|
| Pyridines | 1 | 2007 | 2872 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 4538 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 42217 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9416 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10421 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12983 | 0.010 |
Why?
|
| Aged | 3 | 2009 | 169266 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 10552 | 0.010 |
Why?
|
| Child | 1 | 2017 | 80134 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 23713 | 0.000 |
Why?
|
| Prognosis | 1 | 2008 | 29672 | 0.000 |
Why?
|
| Phenotype | 1 | 2004 | 16572 | 0.000 |
Why?
|
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_